Ramelli Gian Paolo, Hammer Jürg
Department of Paediatrics, Ospedale San Giovanni, Bellinzona, Switzerland.
Swiss Med Wkly. 2005 Oct 1;135(39-40):599-604. doi: 10.4414/smw.2005.11130.
Previous studies have shown that long-term ventilation (LTV) is still not routinely offered to or discussed with patients with Duchenne Muscular Dystrophy (DMD). This is in contrast to the increasing evidence that these interventions can successfully improve quality of life and prolong survival of affected individuals.
The aim of this survey was to describe the clinical practice and the attitudes of Swiss physicians in the respiratory follow up of DMD individuals and to understand better the current provision of respiratory services in Switzerland. Another aim was to explore the contentment of the patients about the provision of information on LTV.
Postal questionnaires requesting information on the current practice of respiratory care were sent to physicians, including pulmonologists and neurologists known or suspected to be involved in the care of children and adults with DMD. 26 of 30 (87%) physicians returned the questionnaire. A second questionnaire was sent to 90 DMD patients of whom 43 (48%) returned the questionnaire.
88% of the physicians indicated to discuss the option of LTV with their patients and families, but 50% of the surveyed physicians start such discussions only after the patient has already developed respiratory failure. Regular pulmonary function assessments are performed by the majority physicians in DMD patients, but only 50% of the physicians perform regular sleep studies to detect sleep disordered breathing.
The majority of Swiss physicians involved in the care of DMD patients disclose information on LTV to DMD patients, but commonly late in the disease course after respiratory problems have developed. The current routine of respiratory follow-up of DMD patients seems insufficient, at least with respect to early detection of nocturnal hypoventilation.
以往研究表明,对于杜氏肌营养不良症(DMD)患者,长期通气(LTV)仍未常规提供给患者或与患者进行讨论。这与越来越多的证据形成对比,这些证据表明这些干预措施能够成功改善患者生活质量并延长其生存期。
本次调查旨在描述瑞士医生对DMD患者进行呼吸随访的临床实践和态度,并更好地了解瑞士目前的呼吸服务提供情况。另一个目的是探讨患者对LTV信息提供的满意度。
向医生发送了要求提供呼吸护理当前实践信息的邮政调查问卷,这些医生包括已知或疑似参与DMD儿童和成人护理的肺病专家和神经科医生。30名医生中有26名(87%)回复了问卷。向90名DMD患者发送了第二份问卷,其中43名(48%)回复了问卷。
88%的医生表示会与患者及其家属讨论LTV选项,但50%的受访医生仅在患者已出现呼吸衰竭后才开始此类讨论。大多数医生对DMD患者进行定期肺功能评估,但只有50%的医生进行定期睡眠研究以检测睡眠呼吸障碍。
大多数参与DMD患者护理的瑞士医生会向DMD患者披露LTV信息,但通常在出现呼吸问题后的疾病进程后期才披露。目前对DMD患者进行呼吸随访的常规做法似乎不足,至少在夜间通气不足的早期检测方面如此。